In a regulatory filing, Pulse Biosciences disclosed that its director Robert Duggan bought 45.6K shares of common stock on December 1st in a total transaction size of $413.6K.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on PLSE:
